Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · IEX Real-Time Price · USD
4.545
-0.025 (-0.55%)
Apr 19, 2024, 11:19 AM EDT - Market open
Achieve Life Sciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ACHV stock have an average target of 16.33, with a low estimate of 11 and a high estimate of 20. The average target predicts an increase of 259.30% from the current stock price of 4.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ACHV stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +340.04% | Apr 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $18 | Buy | Reiterates | $18 | +296.04% | Apr 1, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $19 → $11 | Strong Buy | Maintains | $19 → $11 | +142.02% | Mar 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +296.04% | Dec 12, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +318.04% | May 31, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.06
from -1.50
EPS Next Year
-0.85
from -1.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 71.1M | 223.7M | 334.9M |
| Avg | n/a | n/a | 69.0M | 182.7M | 307.8M |
| Low | n/a | n/a | 66.3M | 142.3M | 278.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 224.1% | 83.3% |
| Avg | - | - | - | 164.6% | 68.5% |
| Low | - | - | - | 106.1% | 52.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.89 | -0.75 | 0.43 | 5.41 | 11.55 |
| Avg | -1.06 | -0.85 | 0.42 | 4.29 | 8.21 |
| Low | -1.35 | -0.91 | 0.40 | 3.20 | 4.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,193.0% | 169.0% |
| Avg | - | - | - | 926.8% | 91.1% |
| Low | - | - | - | 666.3% | 16.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.